
Clinuvel Pharmaceuticals Limited CUV.AX
CUV.AX
Clinuvel Pharmaceuticals Limited PYC.AX
PYC Therapeutics Limited IMM.AX
Immutep Limited HLS.AX
Healius Limited EBR.AX
EBR Systems, Inc. RAC.AX
Race Oncology Limited ACL.AX
Australian Clinical Labs Limited BOT.AX
Botanix Pharmaceuticals Limited OCC.AX
Orthocell Limited OCA.AX
Oceania Healthcare Limited
Clinuvel Pharmaceuticals Limited PYC.AX
PYC Therapeutics Limited IMM.AX
Immutep Limited HLS.AX
Healius Limited EBR.AX
EBR Systems, Inc. RAC.AX
Race Oncology Limited ACL.AX
Australian Clinical Labs Limited BOT.AX
Botanix Pharmaceuticals Limited OCC.AX
Orthocell Limited OCA.AX
Oceania Healthcare Limited
Performance
Periode | CUV.AX | PYC.AX | IMM.AX | HLS.AX | EBR.AX | RAC.AX | ACL.AX | BOT.AX | OCC.AX | OCA.AX |
---|---|---|---|---|---|---|---|---|---|---|
6M | 9.72 % | 14.15 % | 36.44 % | -41.70 % | 1.10 % | 338.95 % | -16.17 % | -62.34 % | -1.47 % | 8.93 % |
YTD | -2.09 % | -3.97 % | -13.52 % | -43.79 % | 25.00 % | 204.38 % | -26.46 % | -67.78 % | -7.59 % | 1.67 % |
1Y | -16.80 % | -38.89 % | 0.66 % | -56.03 % | 28.50 % | 172.55 % | -32.03 % | -59.15 % | 88.73 % | -16.44 % |
3Y | -32.91 % | 87.94 % | 7.83 % | -74.11 % | 147.75 % | 61.63 % | -25.59 % | 116.42 % | 243.59 % | -24.22 % |
5Y | -48.14 % | -30.06 % | 34.24 % | -75.41 % | 34.80 % | 317.00 % | -26.46 % | 45.00 % | 257.33 % | -53.08 % |
10Y | 319.29 % | 782.25 % | -42.91 % | -77.58 % | 34.80 % | 1 473.58 % | -26.46 % | 443.76 % | 109.38 % | -17.57 % |
From the beginning | 283.66 % | -42.65 % | -79.26 % | -12.36 % | 34.80 % | 1 473.58 % | -26.46 % | -99.88 % | 235.00 % | -17.57 % |